ClinicalTrials.Veeva

Menu

Clinical Trial Comparing C-Brace to Knee Ankle Foot Orthosis (KAFO)/Stance Control Orthosis (SCO)

O

Otto Bock Healthcare (Ottobock)

Status

Completed

Conditions

Pareses, Lower Extremity

Treatments

Device: C-Brace
Device: KAFO/SCO

Study type

Interventional

Funder types

Industry

Identifiers

NCT03906656
PS00120016A-001

Details and patient eligibility

About

Prospective, international, multi-center, open-labeled, randomized, controlled cross-over trial to evaluate effectiveness and benefits in patients with lower limb impairment in activities of daily living comparing the C-Brace microprocessor-controlled stance and swing orthosis to standard of care use of knee ankle foot orthosis/stance control orthoses

Full description

After obtaining informed consent, patients will be screened. For subjects fulfilling inclusion/exclusion criteria, a first baseline assessment will be conducted. Within one to two days, a second set of baseline data will be collected for performance measures. Subjects will then be randomly assigned to be fitted with C-Brace or to continue wearing the current KAFO/SCO. After fitting, an accommodation period follows that will last up to 14 days prior to the initial home use. The first follow-up data collection will occur after three months of the initial home use period. Afterwards, the patients will cross over to KAFO/SCO or C-Brace, respectively. The participants who were fitted with C-Brace will cross over to KAFO/SCO and vice versa. Another accommodation phase will be offered for both C-Brace and KAFO/SCO wearers to ensure that subjects can properly use both devices before the cross-over home use period. The second follow-up data collection will occur after 3-months of the cross-over home use period. At the end of the study, the patients can choose to keep the C-Brace for up to 24 months until reimbursement or to return to their original KAFO/SCO.

Enrollment

149 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient has been tested with the Trial Tool (DTO) and demonstrated the potential to utilize the C-Brace successfully
  • Patient has a BBS score < 45
  • Lower limb functional impairment according to CE label wording
  • Prior active and compliant use of unilateral or bilateral KAFO or SCO in the past 3 months prior to enrollment in the study
  • Patient meets minimum physical requirements to be fitted with a C-Brace, such as muscle status, joint mobility, leg axis and proper control of the orthosis must be guaranteed.
  • The User must fulfill the physical and mental requirements for perceiving optical/acoustic signals and/or mechanical vibrations
  • The existing muscle strength of the hip extensors and flexors must permit the controlled swing-through of the limb (compensation using the hip is possible).
  • Patient´s commitment to use C-Brace 2 at least 1-2 hours per day 5 days per week-
  • Patient is ≥ 18 years old
  • Patient is willing and able to independently provide informed consent.
  • Person is willing to comply with study procedures

Exclusion criteria

  • Patient who is not able to follow the entire study visits or is unwilling/unable to follow the instructions
  • Patient was not able to use DTO
  • Patient who is not using an orthosis at least 1 to 2 hours/ day for 5 days per week
  • Patient with body weight > 125 kg (includes body weight and heaviest object (weight) carried)
  • Patient with Orthoprosthesis
  • Patient with flexion contracture in the knee and/or hip joint in excess of 10°
  • Patient with uncontrolled moderate to severe spasticity (relative contraindication moderate spasticity)
  • Leg length discrepancy in excess of 15 cm
  • Patient with unstable neurological or cardiovascular/pulmonary disease, cancer
  • Pregnancy
  • Patient using a C-Brace
  • Patient with known vertigo or with history of falls unrelated to orthosis use or unrelated to motor disability
  • Patient who has never been fitted an orthosis before
  • Patient is not able to answer the self-administered questionnaires independently; for patients with upper extremity impairment is it allowed to verbally answer the questions.
  • Patient participating already in a study during this study´s duration
  • Patient participated in earlier C-Brace studies

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

149 participants in 2 patient groups

KAFO/SCO
Active Comparator group
Description:
Home use of 3 months with existing knee ankle foot orthosis (KAFO) or existing stance control orthosis (SCO)
Treatment:
Device: KAFO/SCO
C-Brace
Experimental group
Description:
Home use of 3 months with newly fitted C-Brace microprocessor-controlled stance and swing control orthosis.
Treatment:
Device: C-Brace

Trial documents
1

Trial contacts and locations

13

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems